Evidence map›Paper›PMID 34608498›Full record

ArticleOncology reports2021

Downregulation of matriptase suppresses the PAR‑2/PLCγ2/PKC‑mediated invasion and migration abilities of MCF‑7 breast cancer cells.

Jeong-Mi Kim, Jinny Park, Eun-Mi Noh, Hyun-Kyung Song, Sang Yull Kang, Sung Hoo Jung, Jong-Suk Kim, Hyun Jo Youn, Young-Rae Lee

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Progress of Platelets in Breast Cancer.Cancer management and research · 2023
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jeong-Mi Kim *Department of Biochemistry, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54896, Republic of Korea.
Jinny Park *Department of Internal Medicine, Division of Hematology, Gil Medical Center, Gachon University College of Medicine, Incheon 405‑760, Republic of Korea.
Eun-Mi NohDepartment of Oral Biochemistry, School of Dentistry, Wonkwang University, Iksan, Jeollabuk 570‑749, Republic of Korea.
Hyun-Kyung SongDepartment of Oral Biochemistry, School of Dentistry, Wonkwang University, Iksan, Jeollabuk 570‑749, Republic of Korea.
Sang Yull KangDepartment of Surgery, Research Institute of Clinical Medicine, Jeonbuk National University Hospital, Jeonbuk National University and Biomedical Research Institute, Jeonju, Jeollabuk 560‑182, Republic of Korea.
Sung Hoo JungDepartment of Surgery, Research Institute of Clinical Medicine, Jeonbuk National University Hospital, Jeonbuk National University and Biomedical Research Institute, Jeonju, Jeollabuk 560‑182, Republic of Korea.
Jong-Suk KimDepartment of Biochemistry, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54896, Republic of Korea.
Hyun Jo YounDepartment of Surgery, Research Institute of Clinical Medicine, Jeonbuk National University Hospital, Jeonbuk National University and Biomedical Research Institute, Jeonju, Jeollabuk 560‑182, Republic of Korea.
Young-Rae LeeDepartment of Oral Biochemistry, School of Dentistry, Wonkwang University, Iksan, Jeollabuk 570‑749, Republic of Korea.
Jeonbuk National University Hospital · KRWonkwang University · KRJeonbuk National University · KRGachon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matriptases, members of the type II transmembrane serine protease family, are cell surface proteolytic enzymes that mediate tumor invasion and metastasis. Matriptase is highly expressed in breast cancer and is associated with poor patient outcome. However, the cellular mechanism by which matriptase mediates breast cancer invasion remains unknown. The present study aimed to determine the role of matriptase in the protein kinase C (PKC)‑mediated metastasis of MCF‑7 human breast cancer cells. Matriptase small interfering RNA‑mediated knockdown significantly attenuated the 12‑

Indexed as

Breast NeoplasmsCell MovementDown-RegulationHumansMatrix Metalloproteinase 9MCF-7 CellsNeoplasm InvasivenessPhospholipase C gammaProtein Kinase CReceptor, PAR-2Serine EndopeptidasesF2RL1 protein, humanmatriptaseMatrix Metalloproteinase 9MMP9 protein, humanPhospholipase C gammaProtein Kinase CReceptor, PAR-2Serine Endopeptidasesbreast cancerinvasionmatriptaseMMP‑9protease‑activated receptor‑2protein kinase C

Identifiers

PMID34608498
PMCPMC8524316
OpenAlexW3204058491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.